Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurship Guest Lecture Series

Publication date: Jan 09, 2013 10:20 AM

Start: Jan 10, 2013 05:15 PM

[image reference is broken]

Rupert Lee Brown - Chief Executive, Caxton FX
Each year, UCL's Department of Management Science and Innovation and UCL Advances organises a series of guest lectures from leading entrepreneurs and investors.

These inspirational speakers provide an insight into the highs and lows of being an entrepreneur and share advice for those wishing to start their own business or who have already embarked on this journey.

Find out more about the Entrepreneurship Guest Lectures